PHARMACEUTICAL PERFORMANCE IN THE EVALUATION AND ADHERENCE TO PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES MELLITUS. REMUNOM, [S. l.], v. 9, n. 1, p. 1–13, 2025. DOI: 10.61164/rmnm.v9i1.3911. Disponível em: https://remunom.ojsbr.com/multidisciplinar/article/view/3911. Acesso em: 12 apr. 2026.